The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo

Oncogene

Volumn 25, Issue 22, 2006, Pages 3104-3112

  Thornton, J K ^a   Dalgleish, C ^a   Venables, J P ^a   Sergeant, K A ^a   Ehrmann, I E ^a   Lu, X ^b   Saunders, P T K ^c   Elliott, D J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Gene expression; Spermatogenesis; Tumour suppressor

Indexed keywords

APOPTOSIS STIMULATING PROTEIN OF P53; CD44V ANTIGEN; GREEN FLUORESCENT PROTEIN; ISOPROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN SAM68; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL NUCLEUS; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPLASM; EXON; GENE EXPRESSION; GERM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TESTIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; ANTIGENS, CD44; CARRIER PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DNA-BINDING PROTEINS; EXONS; GERM CELLS; GREEN FLUORESCENT PROTEINS; HUMANS; KIDNEY; MALE; OSTEOSARCOMA; PHOSPHOPROTEINS; PROTEIN ISOFORMS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TESTIS; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33745074329     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209341     Document Type: Article

References (38)

1. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK et al. (2003). Nat Genet 33: 162-167.
2. Bjorge JD, Jakymiw A, Fujita DJ. (2000). Oncogene 19: 5620-5635.
3. Chen T, Damaj BB, Herrera C, Lasko P, Richard S. (1997). Mol Cell Biol 17: 5707-5718.
4. Coutts AS, La Thangue NB. (2005). Biochem Biophys Res Commun 331: 778-785.
5. Di Fruscio M, Chen T, Bonyadi S, Lasko P, Richard S. (1998). J Biol Chem 273: 30122-30130.
6. Elliott DJ, Bourgeois CF, Klink A, Stevenin J, Cooke HJ. (2000a). Proc Natl Acad Sci USA 97: 5717-5722.
7. Elliott DJ, Venables JP, Newton CS, Lawson D, Boyle S, Eperon IC et al. (2000b). Hum Mol Genet 9: 2117-2124.
8. Forch P, Puig O, Kedersha N, Martinez C, Granneman S, Seraphin B et al. (2000). Mol Cell 6: 1089-1098.
9. Grossman JS, Meyer MI, Wang YC, Mulligan GJ, Kobayashi R, Helfman DM. (1998). Rna 4: 613-625.
10. Harlow E, Lane D. (1999). Using Antibodies. A Laboratory Manual. Cold Spring Harbor Press.
11. Hartmann AM, Nayler O, Schwaiger FW, Obermeier A, Stamm S. (1999). Mol Biol Cell 10: 3909-3926.
12. Hong W, Resnick RJ, Rakowski C, Shalloway D, Taylor SJ, Blobel GA. (2002). Mol Cancer Res 1: 48-55.
13. Liu ZJ, Lu X, Zhang Y, Zhong S, Gu SZ, Zhang XB et al. (2005). FEBS Lett 579: 1587-1590.
14. Liu ZJ, Zhang Y, Zhang XB, Yang X. (2004). Leukemia 18: 880.
15. Lukong KE, Richard S. (2003). Biochim Biophys Acta 1653: 73-86.
16. Maniatis T, Reed R. (2002). Nature 416: 499-506.
17. Matter N, Herrlich P, Konig H. (2002). Nature 420: 691-695.
18. Naumovski L, Cleary ML. (1996). Mol Cell Biol 16: 3884-3892.
19. Paronetto MP, Venables JP, Elliott DJ, Geremia R, Rossi P, Sette C. (2003). Oncogene 22: 8707-8715.
20. Pillay I, Nakano H, Sharma SV. (1996). Cell Growth Differ 7: 1487-1499.
21. Reddy TR, Suhasini M, Xu W, Yeh LY, Yang JP, Wu J et al. (2002). J Biol Chem 277: 5778-5784.
22. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ et al (1994). Nature 370: 527-532.
23. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S et al. (2001). Mol Cell 8: 781-794.
24. Sjoblom T, Lahdetie J. (1996). Oncogene 12: 2499-2505.
25. Slee EA, Gillotin S, Bergamaschi D, Royer C, Llanos S, Ali S et al. (2004). Oncogene 23: 9007-9016.
26. Slee EA, Lu X. (2003). Toxicol Lett 139: 81-87.
27. Smith CW, Valcarcel J. (2000). Trends Biochem Sci 25: 381-388.
28. Stamm S. (2002). Hum Mol Genet 11: 2409-2416.
29. Takahashi N, Kobayashi S, Jiang X, Kitagori K, Imai K, Hibi Y et al. (2004). Biochem Biophys Res Commun 315: 434-438.
30. Taylor SJ, Resnick RJ, Shalloway D. (2004). BMC Cell Biol 5: 5.
31. Venables JP, Dalgliesh C, Paronetto MP, Skitt L, Thornton JK, Saunders PT et al. (2004). Hum Mol Genet 13: 1525-1534.
32. Venables JP, Vernet C, Chew SL, Elliott DJ, Cowmeadow RB, Wu J et al. (1999). Hum Mol Genet 8: 959-969.
33. Vernet C, Artzt K. (1997). Trends Genet 13: 479-484.
34. Vogelstein B, Lane D, Levine AJ. (2000). Nature 408: 307-310.
35. Wyckoff GJ, Wang W, Wu CI. (2000). Nature 403: 304-309.
36. Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T. (1999). Oncogene 18: 5177-5186.
37. Yang JP, Reddy TR, Truong KT, Suhasini M, Wong-Staal F. (2002). Oncogene 21: 7187-7194.
38. Zhang X, Wang M, Zhou C, Chen S, Wang J. (2005). Leuk Res 29: 179-183.